Bruderman Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,366
| Closed | -$37K | – | 519 |
|
|
2019
Q1 | $37K | Hold |
2,366
| – | – | 0.01% | 305 |
|
|
2018
Q4 | $36K | Buy |
2,366
+2,262
| +2,175% | +$34.4K | 0.01% | 281 |
|
|
2018
Q3 | $2K | Buy |
104
+42
| +68% | +$808 | ﹤0.01% | 338 |
|
|
2018
Q2 | $2K | Hold |
62
| – | – | ﹤0.01% | 354 |
|
|
2018
Q1 | $1K | Buy |
+62
| New | +$1K | ﹤0.01% | 345 |
|
|
2017
Q3 | – | Sell |
-62
| Closed | -$2K | – | 299 |
|
|
2017
Q2 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 347 |
|
|
2017
Q1 | – | Sell |
-62
| Closed | -$2K | – | 296 |
|
|
2016
Q4 | $2K | Sell |
62
-315
| -84% | -$10.2K | ﹤0.01% | 350 |
|
|
2016
Q3 | $17K | Buy |
377
+1
| +0.3% | +$45 | 0.01% | 296 |
|
|
2016
Q2 | $19K | Buy |
376
+2
| +0.5% | +$101 | 0.01% | 271 |
|
|
2016
Q1 | $20K | Buy |
374
+2
| +0.5% | +$107 | 0.01% | 270 |
|
|
2015
Q4 | $24K | Buy |
372
+1
| +0.3% | +$65 | 0.01% | 270 |
|
|
2015
Q3 | $21K | Buy |
371
+309
| +498% | +$17.5K | 0.01% | 277 |
|
|
2015
Q2 | $4K | Hold |
62
| – | – | ﹤0.01% | 399 |
|
|
2015
Q1 | $4K | Buy |
+62
| New | +$4K | ﹤0.01% | 388 |
|